Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: once (1000)

VAC31518COV2001_UK_Parent and Guardian ICF_V2.0_15Feb2021_Clean Localised (1)

Description: Southampton NIHR Clinical Research Facility University Hospital Southampton NHS Foundation Trust C Level
Url: /Media/Southampton-Clinical-Research/Downloads/VAC31518COV2001-UK-Parent-and-Guardian-ICF-V2.0-15Feb2021-Clean-Localised-1.pdf

pctdischarge08

Description: <!-- Hide from scriptless browsers snapAddEvent(window, 'load', snapInit); // Global settings var pageNumber=0; var lastPageNumber=0; var pBars=12; var hasSubmitted = false; var showButtons=true; var
Url: /suhtapps/Surveys/pctdischarge08.htm

Lymphoma patient-initiated follow-up - patient information

Description: This booklet explains what patient-initiated follow-up (PIFU) for lymphoma is and what it involves so you know what to
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Lymphoma-patient-initiated-follow-up-475-PIL.pdf

Papers CoG 16.07.2025

Description: Date Time Location Chair Agenda Council of Governors 16/07/2025 14:00 - 15:30 Conference Room, Heartbeat/Microsoft Teams Jenni Douglas-Todd 1 Cha
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Governors/Papers-CoG-16.07.2025.pdf

Cyclophosphamide Docetaxel Epirubicin (100) Fluorouracil Pertuzumab Trastuzumab FE100CT-HP

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-EPIRUBICIN (100)- FLUOROURACILPERTUZUMAB-TRASTUZUMAB (FE100CT-HP)
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Docetaxel-Epirubicin-100-Fluorouracil-Pertuzumab-Trastuzumab-FE100CT-HP.pdf

InP-Ifosfamide-Liposomal Doxorubicin (Caelyx) v1

Description: Chemotherapy Protocol SARCOMA IFOSFAMIDE-LIPOSOMAL DOXORUBICIN (Caelyx) In-Patient Regimen Please note this protocol is based
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Ifosfamide-Liposomal-Doxorubicin-Caelyx-v1.pdf

Liver enhanced recovery - patient information

Description: What to expect in the days before and after your liver resection operation and introducing our liver enhanced recovery programme (ERP
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Liver-enhanced-recovery-2257-PIL.pdf

Choosing where to have your baby - patient information

Description: Choosing where to have your baby Contents Introduction 3 Home birth 4 Birth centres 7 New Forest Birth Centre 8
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Choosingwheretohaveyourbaby.pdf

ObinutuzumabVenetoclax LowRisk

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia Obinutuzumab-Venetoclax (Low Risk) Regimen • CLL – Obinutuzumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/ObinutuzumabVenetoclax-LowRisk.pdf

Engaging for increased research participation - full report

Description: Engaging for increased research participation Public and healthcare professionals' perceptions For further information contact: Chris Sto
Url: /Media/Southampton-Clinical-Research/Marketresearch/Engaging-for-increased-research-participation-full-report-v2.pdf

111 to 120 of 1000

Previous … 10 11 12 13 14 … Next